Diagnostic and therapeutic applications of the glycan biomarker H3N2b in GM1 Gangliosidosis. [PDF]
Kell P +14 more
europepmc +1 more source
Neuraminidase 1 secondary deficiency contributes to CNS pathology in neurological mucopolysaccharidoses via brain protein hypersialylation. [PDF]
Xu T +23 more
europepmc +1 more source
Clavicular Head Subluxation Resulting in Tracheal Compromise in an Osteogenesis Imperfecta Type III Patient: A Case Report. [PDF]
Oommen A, Froass D, Dobish M.
europepmc +1 more source
Mucopolysaccharidoses types I and IIIA: Diagnosis and identification of novel polymorphisms associated with common mutations in Moroccan patients. [PDF]
El Fissi H +5 more
europepmc +1 more source
Explainable AI-driven graph-based neural networks for mucopolysaccharidoses diagnosis. [PDF]
Fadul R +4 more
europepmc +1 more source
Iron metabolism and hematological abnormalities in adult patients affected with mucopolysaccharidoses. [PDF]
Kaciulyte G +10 more
europepmc +1 more source
Challenges and solutions in the treatment of spinal disorders in patients with skeletal dysplasia: A comprehensive review. [PDF]
Tsirikos AI, Jain A, Ahuja K.
europepmc +1 more source
Genetic Modeling of Lysosomal Storage Disorders (LSDs) in the Brain-Midgut Axis of <i>Drosophila melanogaster</i> During Aging. [PDF]
Markaki SP +5 more
europepmc +1 more source
Heparan sulfate binding protein treatment ameliorates neuropathology and behavioral abnormalities in mucopolysaccharidosis IIIB mice. [PDF]
Anzilotti S +10 more
europepmc +1 more source
College of American Pathologists (CAP)/American College of Medical Genetics and Genomics (ACMG) proficiency testing for urinary glycosaminoglycan analysis: A summary of performance. [PDF]
Cusmano-Ozog K +4 more
europepmc +1 more source

